Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
2.690
0.00 (0.00%)
At close: Feb 21, 2025, 4:00 PM
2.680
-0.010 (-0.37%)
After-hours: Feb 21, 2025, 7:48 PM EST
Savara Market Cap
Savara has a market cap or net worth of $563.45 million as of February 21, 2025. Its market cap has decreased by -13.26% in one year.
Market Cap
563.45M
Enterprise Value
370.39M
1-Year Change
-13.26%
Ranking
Category
Stock Price
$2.69
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $563.45M, an increase of 324.60%. That is a compound annual growth rate of 20.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 461.70M | -12.37% |
| Dec 31, 2024 | 526.90M | -17.17% |
| Dec 29, 2023 | 636.10M | 259.79% |
| Dec 30, 2022 | 176.80M | 25.21% |
| Dec 31, 2021 | 141.20M | 126.65% |
| Dec 31, 2020 | 62.30M | -66.25% |
| Dec 31, 2019 | 184.60M | -30.58% |
| Dec 31, 2018 | 265.90M | -41.25% |
| Dec 29, 2017 | 452.60M | 241.07% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |